Class ITerminatedD-0725-2022
Drug recall · March 23, 2022
Avaphinal Maximum Male Enhancement Sexual Pills recall
Why: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.
- Lots / codes
Lot: DK1027, Exp 08/01/2023
- Quantity
- unknown
- Company
- Walmart Stores, Bentonville, AR
- Distribution
- Nationwide in the USA via www.walmart.com
- Initiated
- February 9, 2022 · Voluntary: Firm initiated
- Classified
- March 29, 2022
- Reported
- March 23, 2022
- Ended
- December 2, 2022
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.